BATS BZX Real-Time Price
As of 1:49pm ET
| -0.0084 / -2.71%|
The 2 analysts offering 12-month price forecasts for Protalix Biotherapeutics Inc have a median target of 2.15, with a high estimate of 3.50 and a low estimate of 0.80. The median estimate represents a +612.86% increase from the last price of 0.30.
The current consensus among 2 polled investment analysts is to Buy stock in Protalix Biotherapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.